Athenahealth INC (ATHN) Holder Nikko Asset Management Americas INC Has Lowered Position

September 16, 2018 - By Robert Reynolds

athenahealth, Inc. (NASDAQ:ATHN) LogoInvestors sentiment decreased to 1.2 in 2018 Q2. Its down 0.10, from 1.3 in 2018Q1. It fall, as 39 investors sold ATHN shares while 63 reduced holdings. 49 funds opened positions while 73 raised stakes. 39.58 million shares or 10.95% less from 44.45 million shares in 2018Q1 were reported. Wealthtrust stated it has 129 shares or 0.01% of all its holdings. Nine Masts Cap Limited reported 0% of its portfolio in athenahealth, Inc. (NASDAQ:ATHN). Cibc Asset Mngmt holds 1,437 shares. Oppenheimer Co owns 3,029 shares. Oppenheimer Asset invested in 0.14% or 34,955 shares. Envestnet Asset owns 16,481 shares or 0.01% of their US portfolio. Point72 Asset Limited Partnership holds 53,500 shares or 0.03% of its portfolio. Geode Mgmt Limited Liability Com accumulated 369,042 shares. Dekabank Deutsche Girozentrale, Germany-based fund reported 7,550 shares. 1,667 are owned by M&T Savings Bank. Da Davidson & Com invested 0% in athenahealth, Inc. (NASDAQ:ATHN). 60,000 are owned by State Of New Jersey Common Pension Fund D. Tradewinds Cap Ltd Liability reported 300 shares. Bluestein R H And Co holds 0.01% of its portfolio in athenahealth, Inc. (NASDAQ:ATHN) for 1,524 shares. Schwab Charles Invest Management reported 229,027 shares.

Since March 26, 2018, it had 0 insider buys, and 12 sales for $6.31 million activity. Shares for $3.88 million were sold by Bush Jonathan on Monday, May 7. $165,383 worth of stock was sold by Haley Daniel P on Wednesday, May 16.

Nikko Asset Management Americas Inc decreased its stake in Athenahealth Inc (ATHN) by 9.22% based on its latest 2018Q2 regulatory filing with the SEC. Nikko Asset Management Americas Inc sold 51,820 shares as the company’s stock declined 6.99% while stock markets rallied. The institutional investor held 510,120 shares of the miscellaneous company at the end of 2018Q2, valued at $81.18M, down from 561,940 at the end of the previous reported quarter. Nikko Asset Management Americas Inc who had been investing in Athenahealth Inc for a number of months, seems to be less bullish one the $5.84 billion market cap company. The stock decreased 1.13% or $1.65 during the last trading session, reaching $144.16. About 344,937 shares traded. athenahealth, Inc. (NASDAQ:ATHN) has risen 10.27% since September 16, 2017 and is uptrending. It has underperformed by 5.35% the S&P500.

Nikko Asset Management Americas Inc, which manages about $3.82 billion and $3.35B US Long portfolio, upped its stake in International Business Machine (NYSE:IBM) by 40,619 shares to 72,326 shares, valued at $10.10 million in 2018Q2, according to the filing. It also increased its holding in Netflix Inc (NASDAQ:NFLX) by 14,021 shares in the quarter, for a total of 14,052 shares, and has risen its stake in Splunk Inc (NASDAQ:SPLK).

Analysts await athenahealth, Inc. (NASDAQ:ATHN) to report earnings on October, 18. They expect $0.72 earnings per share, up 89.47 % or $0.34 from last year’s $0.38 per share. ATHN’s profit will be $29.16M for 50.06 P/E if the $0.72 EPS becomes a reality. After $0.88 actual earnings per share reported by athenahealth, Inc. for the previous quarter, Wall Street now forecasts -18.18 % negative EPS growth.

More recent athenahealth, Inc. (NASDAQ:ATHN) news were published by: Bizjournals.com which released: “Former athenahealth CEO has 4.8 million reasons to help sell the company” on September 06, 2018. Also Seekingalpha.com published the news titled: “Cerner and UnitedHealth pass on athenahealth; shares down 1%” on September 06, 2018. Seekingalpha.com‘s news article titled: “Athenahealth up 1% after hours following teaser tweet on sale” with publication date: September 12, 2018 was also an interesting one.

athenahealth, Inc. (NASDAQ:ATHN) Ratings Coverage

Among 13 analysts covering Athenahealth (NASDAQ:ATHN), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Athenahealth has $179 highest and $140 lowest target. $161.08’s average target is 11.74% above currents $144.16 stock price. Athenahealth had 22 analyst reports since April 18, 2018 according to SRatingsIntel. Oppenheimer maintained it with “Buy” rating and $15800 target in Wednesday, April 18 report. Leerink Swann maintained it with “Hold” rating and $15000 target in Tuesday, May 8 report. The company was maintained on Wednesday, June 6 by Cantor Fitzgerald. The firm has “Outperform” rating by Evercore given on Tuesday, May 8. Robert W. Baird maintained the shares of ATHN in report on Tuesday, May 8 with “Outperform” rating. Citigroup maintained it with “Neutral” rating and $140 target in Monday, April 30 report. Citigroup maintained athenahealth, Inc. (NASDAQ:ATHN) on Wednesday, June 6 with “Hold” rating. Cantor Fitzgerald maintained it with “Hold” rating and $14000 target in Thursday, May 24 report. The firm earned “Market Perform” rating on Thursday, June 7 by Leerink Swann. The firm earned “Outperform” rating on Tuesday, June 19 by Oppenheimer.

athenahealth, Inc. (NASDAQ:ATHN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.